Ventilator Developed by University of São Paulo Approved in Human Trials

The device can be built in two hours and is inexpensive, costing only R$1,000 (US$200), whereas the cheapest ventilator on the market today costs 15 times that much, according to the university.

SÃO PAULO, BRAZIL - The emergency lung ventilator developed by a group of USP's Polytechnic School (POLI) engineers to meet the demand for ventilators during the coronavirus pandemic was approved in technical trials and will now be referred to the National Health Surveillance Agency (ANVISA) for clearance.

Human trials were conducted with four patients at the Heart Institute (INCOR) of the Clínicas Hospital (HC) of USP, between April 17th and 19th. According to the technicians' assessment, the ventilator was approved in all modes of use and there were no issues with the ventilated patients.

In addition to the . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?